Search research articles
Contact Us
Filters
Showing results (111-120 of 139) with videos related to
Page
of 14
Sort By:
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
August 1, 1997
ABT-491, a highly potent and selective PAF antagonist, inhibits nasal vascular permeability associated with experimental allergic rhinitis in brown Norway rats
D H Albert, P Tapang, D W Morgan, et al.
Neurology
|
May 1, 1993
Risk factors associated with equine motor neuron disease: a possible model for human MND
H O Mohammed, J F Cummings, T J Divers, et al.
Agents and Actions
|
March 1, 1993
The properties of A-69412: a small hydrophilic 5-lipoxygenase inhibitor
R L Bell, J Bouska, P R Young, et al.
Annals of the New York Academy of Sciences
|
September 6, 1994
Low molecular weight inhibitors in corneal ulceration
R E Galardy, M E Cassabonne, C Giese, et al.
Neurology
|
July 1, 1989
Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS
A J Thompson, C Kennard, M Swash, et al.
Journal of Medicinal Chemistry
|
February 28, 1997
Nonsteroidal anti-inflammatory drugs as scaffolds for the design of 5-lipoxygenase inhibitors
T Kolasa, C D Brooks, K E Rodriques, et al.
The Journal of Biological Chemistry
|
May 23, 2003
Rab5-stimulated up-regulation of the endocytic pathway increases intracellular beta-cleaved amyloid precursor protein carboxyl-terminal fragment levels and Abeta production
Olivera M Grbovic, Paul M Mathews, Ying Jiang, et al.
Journal of Medicinal Chemistry
|
November 1, 1987
In vivo characterization of hydroxamic acid inhibitors of 5-lipoxygenase
J B Summers, B P Gunn, H Mazdiyasni, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
July 1, 1997
Ex vivo inhibition of beta-thromboglobulin release following administration to man of ABT-299, a novel prodrug of a potent platelet activating factor antagonist
D H Albert, T J Magoc, S D Menacherry, et al.
Journal of Medicinal Chemistry
|
December 23, 1994
N-(acyloxyalkyl)pyridinium salts as soluble prodrugs of a potent platelet activating factor antagonist
S K Davidsen, J B Summers, D H Albert, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 139) with videos related to
Sort By:
Page
of 14
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
August 1, 1997
ABT-491, a highly potent and selective PAF antagonist, inhibits nasal vascular permeability associated with experimental allergic rhinitis in brown Norway rats
D H Albert, P Tapang, D W Morgan, et al.
Neurology
|
May 1, 1993
Risk factors associated with equine motor neuron disease: a possible model for human MND
H O Mohammed, J F Cummings, T J Divers, et al.
Agents and Actions
|
March 1, 1993
The properties of A-69412: a small hydrophilic 5-lipoxygenase inhibitor
R L Bell, J Bouska, P R Young, et al.
Annals of the New York Academy of Sciences
|
September 6, 1994
Low molecular weight inhibitors in corneal ulceration
R E Galardy, M E Cassabonne, C Giese, et al.
Neurology
|
July 1, 1989
Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS
A J Thompson, C Kennard, M Swash, et al.
Journal of Medicinal Chemistry
|
February 28, 1997
Nonsteroidal anti-inflammatory drugs as scaffolds for the design of 5-lipoxygenase inhibitors
T Kolasa, C D Brooks, K E Rodriques, et al.
The Journal of Biological Chemistry
|
May 23, 2003
Rab5-stimulated up-regulation of the endocytic pathway increases intracellular beta-cleaved amyloid precursor protein carboxyl-terminal fragment levels and Abeta production
Olivera M Grbovic, Paul M Mathews, Ying Jiang, et al.
Journal of Medicinal Chemistry
|
November 1, 1987
In vivo characterization of hydroxamic acid inhibitors of 5-lipoxygenase
J B Summers, B P Gunn, H Mazdiyasni, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
July 1, 1997
Ex vivo inhibition of beta-thromboglobulin release following administration to man of ABT-299, a novel prodrug of a potent platelet activating factor antagonist
D H Albert, T J Magoc, S D Menacherry, et al.
Journal of Medicinal Chemistry
|
December 23, 1994
N-(acyloxyalkyl)pyridinium salts as soluble prodrugs of a potent platelet activating factor antagonist
S K Davidsen, J B Summers, D H Albert, et al.
Page
of 14